| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Dec 28, 2020 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 538 | $135.00 | $72,630.00 | -10.4% | |
| Dec 28, 2020 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 8,750 | $140.04 | $1,225,390.17 | - | |
| Dec 28, 2020 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 8,750 | $140.04 | $1,225,390.17 | - | |
| Dec 23, 2020 | IMDX Insight Molecular Diagnostics Inc. | Kingsley Alfred D | - | Sell | 900 | $2.55 | $2,295.00 | -0.3% | |
| Dec 23, 2020 | IQV Iqvia Holdings Inc. | Danhakl John G60 | Director | Buy | 63,451 | $176.95 | $11,227,654.45 | +85.8% | |
| Dec 22, 2020 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 33,260 | $140.01 | $4,656,732.60 | -0.5% | |
| Dec 22, 2020 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 33,260 | $140.01 | $4,656,732.60 | -0.5% | |
| Dec 22, 2020 | IMDX Insight Molecular Diagnostics Inc. | Kingsley Alfred D | - | Sell | 42,800 | $0.31 | $13,075.92 | -4.3% | |
| Dec 18, 2020 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 6,250 | $62.60 | $391,269.01 | -0.1% | |
| Dec 18, 2020 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 216,048 | $141.85 | $30,646,408.80 | -3.2% | |
| Dec 18, 2020 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 8,363 | $68.01 | $568,800.93 | -2.4% | |
| Dec 18, 2020 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 216,048 | $141.85 | $30,646,408.80 | -3.2% | |
| Dec 18, 2020 | RDNT Radnet, Inc. | Hames Norman R56 | President, Western Operations | Sell | 15,000 | $18.48 | $277,150.00 | -2.0% | |
| Dec 17, 2020 | PSNL Personalis, Inc. | Tachibana Aaron68 | Chief Financial Officer | Sell | 2,391 | $36.37 | $86,960.67 | -1.4% | |
| Dec 17, 2020 | NDRA Endra Life Sciences Inc. | Maloberti Renaud Bertrand | Chief Commercial Officer | Sell | 25,000 | $0.73 | $18,250.00 | -37.5% | |
| Dec 17, 2020 | RDNT Radnet, Inc. | Hames Norman R56 | President, Western Operations | Sell | 15,000 | $18.86 | $282,900.00 | -3.8% | |
| Dec 17, 2020 | PSNL Personalis, Inc. | Chen Richard70 | Chief Scientific Officer | Sell | 1,087 | $36.37 | $39,534.19 | -1.0% | |
| Dec 17, 2020 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 12,500 | $65.54 | $819,305.96 | - | |
| Dec 16, 2020 | CSTL Castle Biosciences Inc | Cook Joseph C. III | Director | Sell | 169,900 | $66.29 | $11,262,796.46 | -2.0% | |
| Dec 16, 2020 | RDNT Radnet, Inc. | Hames Norman R56 | President, Western Operations | Sell | 25,000 | $19.01 | $475,300.00 | -2.0% | |
| Dec 15, 2020 | XGN Exagen Inc. | Tullis James L L73 | Director, 10% Owner | Sell | 12,000 | $12.23 | $146,726.40 | -0.8% | |
| Dec 15, 2020 | BIO Bio-Rad Laboratories, Inc. | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 374 | $580.67 | $217,170.58 | -9.3% | |
| Dec 15, 2020 | XGN Exagen Inc. | Nmsic Co-Investment Fund, L.P. | 10% Owner | Sell | 125,000 | $12.00 | $1,500,562.50 | -5.1% | |
| Dec 14, 2020 | EXAS Exact Sciences Corp | Zanotti Katherine S50 | Director | Sell | 20,000 | $132.06 | $2,641,182.32 | -14.8% | |
| Dec 14, 2020 | RVTY Revvity, Inc. | Tereau Daniel R69 | Please See Remarks | Sell | 4,094 | $146.68 | $600,507.92 | -35.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.